Ken Griffin HALOZYME THERAPEUTICS INC Transaction History

Citadel Advisors LLC

  • $550 Billion
  • Q2 2025
Number of Shares
19,620,000
Previous 52,620,000 62.71%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-33,000,000 Reduced 62.71%
19,620,000 $0
Q1 2025

May 15, 2025
BUY
N/A
14,249,000 Added 37.13%
52,620,000 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-20,000,000 Reduced 34.26%
38,371,000 $0
Q3 2024

Nov 14, 2024
BUY
N/A
45,171,000 Added 342.2%
58,371,000 $0
Q2 2024

Aug 14, 2024
BUY
N/A
3,106,000 Added 30.77%
13,200,000 $0
Q1 2024

May 15, 2024
SELL
N/A
-23,115,000 Reduced 69.6%
10,094,000 $0
Q4 2023

Feb 14, 2024
SELL
N/A
-14,662,000 Reduced 30.63%
33,209,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
47,871,000 New
47,871,000 $0
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email